HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Online-Only Appendix All Versions of this Article: db07-0275v1 56/9/2349    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Skov, V. Articles by Højlund, K. Search for Related Content PubMed PubMed Citation Articles by Skov, V. Articles by Højlund, K. Social Bookmarking                What's this?

Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin resistant women with polycystic ovary syndrome.

¹Department of Biochemistry, Genetics, and Pharmacology, Odense University Hospital and Human Microarray Centre (HUMAC), University of Southern Denmark, DK-5000 Odense, Denmark
²Department of Endocrinology, Odense University Hospital, DK-5000 Odense, Denmark
³Medical Prognosis Institute Aps, DK-2979 Hørsholm, Denmark
⁴Institute of Public Health, University of Southern Denmark, DK-5000 Odense, Denmark

Correspondence: vibe.skov{at}ouh.regionsyddanmark.dk

Objective:Insulin resistance in skeletal muscle is a major risk factor for the development of type 2 diabetes in women with polycystic ovary syndrome (PCOS). In patients with type 2 diabetes, insulin resistance in skeletal muscle is associated with abnormalities in insulin signaling, fatty acid metabolism, and mitochondrial oxidative phosphorylation (OXPHOS). In PCOS patients, the molecular mechanisms of insulin resistance are, however, less well characterized.

Research Design and Methods:To identify biological pathways of importance for the pathogenesis of insulin resistance in PCOS, we compared gene expression in skeletal muscle of metabolically characterized PCOS patients (n=16) and healthy control subjects (n=13) using two different approaches for global pathway analysis; Gene Set Enrichment Analysis (GSEA 1.0) and Gene Map Annotator and Pathway Profiler (GenMAPP 2.0).

Results:We demonstrate that impaired insulin-stimulated total, oxidative and non-oxidative glucose disposal in PCOS patients are associated with a consistent downregulation of OXPHOS gene expression using both GSEA and GenMAPP analysis. Quantitative real-time PCR (q-RT-PCR) analysis validated these findings and showed that reduced levels of PGC-1 could play a role for the downregulation of OXPHOS genes in PCOS.

Conclusions:In these women with PCOS, the decrease in OXPHOS gene expression in skeletal muscle can not be ascribed to obesity and diabetes. This supports the hypothesis of an early association between insulin resistance and impaired mitochondrial oxidative metabolism, which is, in part, mediated by reduced PGC-1 levels. These abnormalities may contribute to the increased risk of type 2 diabetes observed in women with PCOS.

CiteULike

Del.icio.us

Digg

Reddit

Technorati